Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Chada

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Cancer Research|August 28, 2003
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptorRajagopal Ramesh, Abner M Mhashilkar, Fumihiro Tanaka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patientsAlex W Tong, John Nemunaitis, Dan Su, et al.
Molecular Medicine (Cambridge, Mass.)|November 19, 2002
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cellsAlexis L Stewart, Abner M Mhashilkar, Xiaohong Helena Yang, et al.
International Immunopharmacology|May 4, 2004
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 familySunil Chada, R Bryan Sutton, Suhendan Ekmekcioglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and NeckJohn Nemunaitis, Gary Clayman, Sanjiv S Agarwala, et al.
International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Cancer Research|August 28, 2003
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptorRajagopal Ramesh, Abner M Mhashilkar, Fumihiro Tanaka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patientsAlex W Tong, John Nemunaitis, Dan Su, et al.
Molecular Medicine (Cambridge, Mass.)|November 19, 2002
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cellsAlexis L Stewart, Abner M Mhashilkar, Xiaohong Helena Yang, et al.
International Immunopharmacology|May 4, 2004
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 familySunil Chada, R Bryan Sutton, Suhendan Ekmekcioglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and NeckJohn Nemunaitis, Gary Clayman, Sanjiv S Agarwala, et al.
International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
Pageof 7